
### [NCIT:C133156](http://purl.obolibrary.org/obo/NCIT_C133156)
**Label:** Laryngeal Cancer by AJCC v8 Stage

**Subclasses:** [NCIT:C133158](http://purl.obolibrary.org/obo/NCIT_C133158) (Stage I Laryngeal Cancer AJCC v8), [NCIT:C133159](http://purl.obolibrary.org/obo/NCIT_C133159) (Stage II Laryngeal Cancer AJCC v8), [NCIT:C133160](http://purl.obolibrary.org/obo/NCIT_C133160) (Stage III Laryngeal Cancer AJCC v8), [NCIT:C133161](http://purl.obolibrary.org/obo/NCIT_C133161) (Stage IV Laryngeal Cancer AJCC v8), [NCIT:C6121](http://purl.obolibrary.org/obo/NCIT_C6121) (Stage 0 Laryngeal Squamous Cell Carcinoma AJCC v6, v7, and v8), [NCIT:C9100](http://purl.obolibrary.org/obo/NCIT_C9100) (Stage 0 Laryngeal Cancer AJCC v6, v7, and V8), 

**Class expressions from DL-Learner:**

- [NCIT:C132248](http://purl.obolibrary.org/obo/NCIT_C132248) (AJCC v8 Stage) 53.33%
- Thing 53.10%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) 38.69%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40378](http://purl.obolibrary.org/obo/NCIT_C40378) (Post-Radiotherapy Breast Angiosarcoma))) 38.69%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40377](http://purl.obolibrary.org/obo/NCIT_C40377) (Breast Follicular Lymphoma))) 38.69%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40376](http://purl.obolibrary.org/obo/NCIT_C40376) (Breast Burkitt Lymphoma))) 38.69%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40375](http://purl.obolibrary.org/obo/NCIT_C40375) (Breast Diffuse Large B-Cell Lymphoma))) 38.69%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C4037](http://purl.obolibrary.org/obo/NCIT_C4037) (Acute Myeloid Leukemia Arising from Previous Myelodysplastic Syndrome))) 38.69%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40369](http://purl.obolibrary.org/obo/NCIT_C40369) (Sebaceous Breast Carcinoma))) 38.69%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40367](http://purl.obolibrary.org/obo/NCIT_C40367) (Acinic Cell Breast Carcinoma))) 38.69%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40366](http://purl.obolibrary.org/obo/NCIT_C40366) (Oncocytic Breast Carcinoma))) 38.69%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40363](http://purl.obolibrary.org/obo/NCIT_C40363) (Nipple Syringomatous Adenoma))) 38.69%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40362](http://purl.obolibrary.org/obo/NCIT_C40362) (Low Grade Adenosquamous Breast Carcinoma))) 38.69%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40358](http://purl.obolibrary.org/obo/NCIT_C40358) (Squamous Cell Breast Carcinoma, Spindle Cell Variant))) 38.69%
- [NCIT:C37153](http://purl.obolibrary.org/obo/NCIT_C37153) (Malignant Stromal Cell) and (not ([NCIT:C40356](http://purl.obolibrary.org/obo/NCIT_C40356) (Breast Large Cell Neuroendocrine Carcinoma))) 38.69%


